PUBLISHER: KBV Research | PRODUCT CODE: 1093176
PUBLISHER: KBV Research | PRODUCT CODE: 1093176
Europe Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Country and Growth Forecast, 2022 - 2028
The Europe Analgesics Market would witness market growth of 6.2% CAGR during the forecast period (2022-2028).
The most often used OTC analgesic is paracetamol. It has analgesic properties similar to aspirin and ibuprofen. There are no anti-inflammatory properties in it. Within the central nervous system, paracetamol suppresses prostaglandin production. It is the most commonly used analgesic for pain relief. The anticoagulant impact of coumarins may be enhanced by long-term usage of paracetamol. Hypersensitivity and rare occurrences of blood dyscrasias are common adverse effects of paracetamol, including agranulocytosis and thrombocytopenia. Another typical OTC analgesic is aspirin. Analgesic, antiplatelet, antipyretic, and anti-inflammatory are properties of aspirin. Aspirin's analgesic action is due to the suppression of cyclooxygenase. Epigastric discomfort, nausea and vomiting, gastrointestinal ulceration, hypersensitivity, and arthritis are all antagonistic effects of aspirin.
The healthcare sector of this region is significantly robust, which is allowing major market players to increase their efforts and investments in the advancement of the regional healthcare infrastructure. The European Commission announced the introduction of the European Research Area (ERA) corona platform in May 2020, which would give information on coronavirus research and innovation. In addition, the European Medicines Agency has recommended that mild COVID-19 symptoms be treated with non-steroidal anti-inflammatories (NSAIDs), such as paracetamol and ibuprofen, in the lowest dose form. Furthermore, because elderly people are more vulnerable to infection due to weakening immune systems and the lack of a vaccine or therapy, the number of older persons infected with coronavirus is high. The utilization of analgesics are increasing in the region in order to treat the side-effects of this.
The Germany market dominated the Europe Analgesics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,880.8 Million by 2028. The UK market is poised to grow at a CAGR of 5.3% during (2022 - 2028). Additionally, The France market would witness a CAGR of 7% during (2022 - 2028).
Based on Type, the market is segmented into Non-opioids and Opioids. Based on Route of Administration, the market is segmented into Oral, Transdermal, Intravenous, Topical, and Rectal. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Reckitt Benckiser Group PLC, Abbott Laboratories, Johnson & Johnson, Bayer AG, Endo International PLC, GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., and Eli Lilly And Company.
Scope of the Study
Market Segments covered in the Report:
By Type
- Non-opioids
- Opioids
By Route of Administration
- Oral
- Transdermal
- Intravenous
- Topical
- Rectal
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- AbbVie, Inc.
- Reckitt Benckiser Group PLC
- Abbott Laboratories
- Johnson & Johnson
- Bayer AG
- Endo International PLC
- GlaxoSmithKline PLC
- Pfizer, Inc.
- Sanofi S.A.
- Eli Lilly And Company
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Analgesics Market, by Type
- 1.4.2 Europe Analgesics Market, by Route of Administration
- 1.4.3 Europe Analgesics Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies deployed in Analgesics Market
Chapter 4. Europe Analgesics Market by Type
- 4.1 Europe Macro processing Market by Country
- 4.2 Europe Micro processing Market by Country
Chapter 5. Europe Analgesics Market by Route of Administration
- 5.1 Europe Oral Market by Country
- 5.2 Europe Transdermal Market by Country
- 5.3 Europe Intravenous Market by Country
- 5.4 Europe Topical Market by Country
- 5.5 Europe Rectal Market by Country
Chapter 6. Europe Analgesics Market by Country
- 6.1 Germany Analgesics Market
- 6.1.1 Germany Analgesics Market by Type
- 6.1.2 Germany Analgesics Market by Route of Administration
- 6.2 UK Analgesics Market
- 6.2.1 UK Analgesics Market by Type
- 6.2.2 UK Analgesics Market by Route of Administration
- 6.3 France Analgesics Market
- 6.3.1 France Analgesics Market by Type
- 6.3.2 France Analgesics Market by Route of Administration
- 6.4 Russia Analgesics Market
- 6.4.1 Russia Analgesics Market by Type
- 6.4.2 Russia Analgesics Market by Route of Administration
- 6.5 Spain Analgesics Market
- 6.5.1 Spain Analgesics Market by Type
- 6.5.2 Spain Analgesics Market by Route of Administration
- 6.6 Italy Analgesics Market
- 6.6.1 Italy Analgesics Market by Type
- 6.6.2 Italy Analgesics Market by Route of Administration
- 6.7 Rest of Europe Analgesics Market
- 6.7.1 Rest of Europe Analgesics Market by Type
- 6.7.2 Rest of Europe Analgesics Market by Route of Administration
Chapter 7. Company Profiles
- 7.1 AbbVie, Inc. (Allergan PLC)
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Approvals and Trials:
- 7.2 Reckitt Benckiser Group PLC
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Product Launches and Product Expansions:
- 7.3 Abbott Laboratories
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Product Launches and Product Expansions:
- 7.3.5.2 Approvals and Trials:
- 7.4 Johnson & Johnson
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental &Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.5 Bayer AG
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Product Launches and Product Expansions:
- 7.6 Endo International PLC
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expense
- 7.7 GlaxoSmithKline PLC
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 Recent strategies and developments:
- 7.7.5.1 Partnerships, Collaborations, and Agreements:
- 7.7.5.2 Geographical Expansions:
- 7.8 Pfizer, Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional & Segmental Analysis
- 7.8.4 Research & Development Expense
- 7.8.5 Recent strategies and developments:
- 7.8.5.1 Partnerships, Collaborations, and Agreements:
- 7.9 Sanofi S.A.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
- 7.10. Eli Lilly And Company
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Regional Analysis
- 7.10.4 Research & Development Expenses
- 7.10.5 Recent strategies and developments:
- 7.10.5.1 Partnerships, Collaborations, and Agreements:
- 7.10.5.2 Geographical Expansions:
LIST OF TABLES
- TABLE 1 Europe Analgesics Market, 2018 - 2021, USD Million
- TABLE 2 Europe Analgesics Market, 2022 - 2028, USD Million
- TABLE 3 Europe Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 4 Europe Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 5 Europe Macro processing Market by Country, 2018 - 2021, USD Million
- TABLE 6 Europe Macro processing Market by Country, 2022 - 2028, USD Million
- TABLE 7 Europe Micro processing Market by Country, 2018 - 2021, USD Million
- TABLE 8 Europe Micro processing Market by Country, 2022 - 2028, USD Million
- TABLE 9 Europe Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 10 Europe Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 11 Europe Oral Market by Country, 2018 - 2021, USD Million
- TABLE 12 Europe Oral Market by Country, 2022 - 2028, USD Million
- TABLE 13 Europe Transdermal Market by Country, 2018 - 2021, USD Million
- TABLE 14 Europe Transdermal Market by Country, 2022 - 2028, USD Million
- TABLE 15 Europe Intravenous Market by Country, 2018 - 2021, USD Million
- TABLE 16 Europe Intravenous Market by Country, 2022 - 2028, USD Million
- TABLE 17 Europe Topical Market by Country, 2018 - 2021, USD Million
- TABLE 18 Europe Topical Market by Country, 2022 - 2028, USD Million
- TABLE 19 Europe Rectal Market by Country, 2018 - 2021, USD Million
- TABLE 20 Europe Rectal Market by Country, 2022 - 2028, USD Million
- TABLE 21 Europe Analgesics Market by Country, 2018 - 2021, USD Million
- TABLE 22 Europe Analgesics Market by Country, 2022 - 2028, USD Million
- TABLE 23 Germany Analgesics Market, 2018 - 2021, USD Million
- TABLE 24 Germany Analgesics Market, 2022 - 2028, USD Million
- TABLE 25 Germany Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 26 Germany Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 27 Germany Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 28 Germany Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 29 UK Analgesics Market, 2018 - 2021, USD Million
- TABLE 30 UK Analgesics Market, 2022 - 2028, USD Million
- TABLE 31 UK Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 32 UK Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 33 UK Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 34 UK Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 35 France Analgesics Market, 2018 - 2021, USD Million
- TABLE 36 France Analgesics Market, 2022 - 2028, USD Million
- TABLE 37 France Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 38 France Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 39 France Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 40 France Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 41 Russia Analgesics Market, 2018 - 2021, USD Million
- TABLE 42 Russia Analgesics Market, 2022 - 2028, USD Million
- TABLE 43 Russia Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 44 Russia Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 45 Russia Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 46 Russia Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 47 Spain Analgesics Market, 2018 - 2021, USD Million
- TABLE 48 Spain Analgesics Market, 2022 - 2028, USD Million
- TABLE 49 Spain Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 50 Spain Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 51 Spain Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 52 Spain Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 53 Italy Analgesics Market, 2018 - 2021, USD Million
- TABLE 54 Italy Analgesics Market, 2022 - 2028, USD Million
- TABLE 55 Italy Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 56 Italy Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 57 Italy Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 58 Italy Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 59 Rest of Europe Analgesics Market, 2018 - 2021, USD Million
- TABLE 60 Rest of Europe Analgesics Market, 2022 - 2028, USD Million
- TABLE 61 Rest of Europe Analgesics Market by Type, 2018 - 2021, USD Million
- TABLE 62 Rest of Europe Analgesics Market by Type, 2022 - 2028, USD Million
- TABLE 63 Rest of Europe Analgesics Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 64 Rest of Europe Analgesics Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 65 Key information - AbbVie, Inc.
- TABLE 66 Key information - Reckitt Benckiser Group PLC
- TABLE 67 Key Information - Abbott Laboratories
- TABLE 68 Key information - Johnson & Johnson
- TABLE 69 Key Information - Bayer AG
- TABLE 70 Key Information - Endo International PLC
- TABLE 71 Key Information - GlaxoSmithKline PLC
- TABLE 72 Key Information - Pfizer, Inc.
- TABLE 73 Key Information - Sanofi S.A.
- TABLE 74 Key Information - Eli Lilly And Company
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Recent strategies and developments: Abbott Laboratories
- FIG 3 Recent strategies and developments: Eli Lilly And Company
